MAWAG
MRNA icon

Mid-American Wealth Advisory Group’s Moderna MRNA Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-36
Closed -$993 – 210
2025
Q2 		$993 Buy
+36
New +$948 ﹤0.01% 290

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mid-American Wealth Advisory Group's MRNA Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of Moderna (MRNA) in Q3 2025, closing a stake of 36 shares — an estimated $993 sold.

Mid-American Wealth Advisory Group first reported a position in MRNA in Q2 2025 and held it in 1 quarter. The position peaked at $993 in Q2 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Mid-American Wealth Advisory Group reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Mid-American Wealth Advisory Group sold 36 Moderna shares in Q3 2025, an estimated $993.
  • Mid-American Wealth Advisory Group first reported a position in Moderna in Q2 2025 and held it in 1 quarter.
  • Mid-American Wealth Advisory Group's Moderna position peaked at $993 in Q2 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.